Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact email@example.com.
SOURCE San MediTech
SAN FRANCISCO, June 13, 2014 /PRNewswire/ -- San MediTech, the industry leader in dynamic glucose monitoring technology, will attend the American Diabetes Association (ADA) 74th Scientific Sessions in San Francisco, June 13-17, 2014. Only a handful of companies in the world have successfully developed dynamic glucose monitoring technology, with San MediTech being one of them. The world's first mHealth (Mobile Health) Dynamic Glucose Monitoring System (DGMS) -- San Meditech mHealth' CGM, the most specialized and advanced product in the mHealth field, will be presented at the ADA sessions.
Experts from the company's Research and Development Department, Marketing Department will show and explain the latest technology and all-round dynamic glucose monitoring solution to visitors at San MediTech's booth (Booth No.1245). Besides, the innovative San Meditech mHealth' CGM will be showcased at the sessions. San Meditech mHealth' CGM is equipped with Bluetooth BT4.0, which was freshly released last year, and is adaptable to the upcoming i.s.o.8.0 system. This innovative combination is beyond traditional healthcare's imagination. San MediTech currently has no competitive rivals in the mHealth Dynamic Glucose Monitoring field.
Hao Gang, Chairman of San MediTech, stated: "This is the fourth time San MediTech has attended ADA. The ADA Sessions, a wind vane in the prevention and cure of diabetes worldwide, is the top-level seminar in the diabetes research area and an information platform of the latest findings from all over the world. We are honored to be part of it. San MediTech is committed to developing and promoting Dynamic Glucose Monitoring products. San Meditech mHealth' CGM, a new product released by our company, aims to facilitate the application for users to the greatest extent possible. With it, users can monitor their glucose anytime anywhere and assess everyday events, including diet, sports and medication, to help diabetics control glucose. ADA provides us with an excellent business opportunity, and we are looking forward to communicating with clients, giving them an insight to our technology prowess and service capabilities, therefore reaping more cooperation opportunities."
About San MediTech:
San MediTech, founded in 2003, is a specialized developer and marketer of Dynamic Glucose Monitoring products, which owns several world-leading patent technologies in the field. The company has been working on developing different Dynamic Glucose Monitoring products for both hospitals and individuals to serve specific uses, helping diabetics take advantage of the world's most advanced technology to control glucose.
The American Diabetes Association's Scientific Sessions is the largest diabetes meeting in the world, bringing together thousands of participants from America and the world-including experts, professors, clinicians and researchers. The latest research findings from every corner of the world and famous universities and research institutes in America will be presented at the sessions. The ADA Sessions, a wind vane in the prevention and cure of diabetes worldwide, is the top-level seminar in diabetes research area. At the sessions, industry experts, professors and attendees will exchange latest information about diabetes research, their views, opinions, comments and information about their ongoing scientific research activities in their labs.
©2012 PR Newswire. All Rights Reserved.